Neuromod Redefines Tinnitus Care
Neuromod is the global medical technology company who are responsible for the development of tinnitus treatment device, Lenire.

Neuromodulation patents for tinnitus treatment across 37 countries.
Clinicians providing Lenire across Europe and the United States of America.
FDA Approved bimodal neuromodulation tinnitus treatment device – Lenire.
Setting a New Standard for Tinnitus Care

Neuromod is redefining care for tinnitus patients through scientific innovation, clinical practice-enablement and an uncompromising patient-centric approach.

FDA Approved Tinnitus Treatment Device

Lenire is the first and only FDA Approved bimodal neuromodulation tinnitus treatment device that has been proven safe and effective in three large scale clinical trials.

Developing and Trialing Innovative Technology

Lenire has been proven safe and effective across three large-scale clinical trials involving more than 600 patients. Read more about Lenire’s pivotal clinical trials.

Neuromod Partnerships
We are proud to be working with a number of partners who share our vision for revolutionising tinnitus patient care.









Find a Lenire Clinic

Lenire is available in more than 130 clinics across the United States of America and Europe. Book an appointment with a leading tinnitus expert and start your tinnitus treatment journey.
Find a Lenire Provider